-
BioNet and BIA Separations Collaborate on mRNA Manufacturing Process
ContractPharma
November 03, 2021
BioNet, a biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a biochromatography development and manufacturing company...
-
UK genomics market valued at over £5bn, according to new report
pharmatimes
August 02, 2021
A new report has revealed the strength of the UK’s genomics sector for investors, patients and the UK economy, adding that the sector has a market of over £5bn.
-
2020 – the best year for UK biotech investments ever recorded, says BIA
europeanpharmaceuticalreview
February 07, 2021
Report finds 2020 was a record-breaking year for investment in UK biotech, driven by innovation and the COVID-19 pandemic, with growth anticipated to continue into 2021.
-
Government funding for UK biomedical innovation insufficient, BIA says
europeanpharmaceuticalreview
November 26, 2020
According to the BIA, less than four percent of eligible projects received funding from a government programme for early-stage biotech companies.
-
UK biotech consortium identifies COVID-19 antibody combinations
pharmatimes
October 30, 2020
The UK BIA Antibody Taskforce, a UK consortium developing antibodies for treating COVID-19, has identified differentiated antibody combinations to take further into development as as an antibody cocktail.
-
UK biotech companies raise over £1bn in record quarter
pharmatimes
October 15, 2020
In new data published by the BioIndustry Association (BIA) and Clarivate, UK biotech companies reportedly raised over £1bn in equity finance between June and August 2020.
-
£14m funding to support rapid COVID-19 vaccine manufacturing scale up
europeanpharmaceuticalreview
April 30, 2020
The UK Bioindustry Association industry-led vaccine manufacturing group has welcomed a £14 million investment to support COVID-19 vaccine manufacturing.
-
AveXis, BIA Ink Gene Therapy Manufacturing Process Development Deal
contractpharma
July 29, 2019
BIA to provide expertise in next generation biomolecule purification processes and long-term supply of CIMmultus monolithic columns.
-
BIA report: 2018 was a record year for UK biotech fundraising
pharmaceutical-technology
January 25, 2019
A report by the UK Bio Industry Association (BIA) and Informa Pharmaceutical Intelligence recorded that the UK biotech sector raised £2.2bn from investors in 2018.....
-
Real-world data prove efficacy of Eisai and Bial's epilepsy treatment
pharmafile
September 07, 2017
Bial and Eisai have released real-world data which support the efficacy of Zebinix (eslicarbazepine acetate) in the treatment of partial-onset epilepsy in adults